OPTIMIZATION OF PCL-PEG-PCL TRIBLOCK COPOLYMER MICELLES AS HYDROPHOBIC DRUG CARRIER WITH A 22 FULL FACTORIAL DESIGN
Objective: This study aims to optimize PCL-PEG-PCL (PCEC) triblock copolymer micelles as a hydrophobic drug carrier, simvastatin (SV).
Methods: PCEC triblock copolymer was prepared by the ring-opening polymerization method (ROP) with different ɛCL/PEG ratio (2 and 5). SV was incorporated into the PCEC triblock copolymer micelles with a concentration of 2.5 and 10 % w/w by the solvent evaporation method (film formation). The influence of the ɛCL/PEG ratio and concentration of SV effect on the responses particle size (PS), polydispersity index (PI) and entrapment efficiency (EE) was assessed using 22 full factorial design method. The test results were analyzed using Design-Expert software to obtain the optimum formula.
Result: The selection of the optimum formula is based on the desirability value, the formula with the largest desirability value is chosen as the optimum formula. The results showed the optimum formula chosen had a desirability value of 0.860 consisting of a ɛCL/PEG ratio of 5 and SV concentration of 10 % w/w, with the PS, PI dan EE value was 322.1±3.51 nm, 0.471±0.09 and 87.08±1.17 %, respectively.
Conclusion: The 22 full factorial design has been proven to be used as an optimization method to determine the optimum formula of SV-loaded PCEC triblock copolymer micelles with a good result of the PS, PI and EE responses.
2. Narang AS, Mahato RI. Targeted delivery of a small and macromolecular drug. New York: CRC Press; 2010.
3. Zamani S, Khoee S. Preparation of core-shell chitosan/PCL-PEG triblock copolymer nanoparticles with aba and bab morphologies: effect of intraparticle interactions on physicochemical properties. Polymer 2012;53:5723-36.
4. Jiang T, Han N, Zhao B, Xie Y, Wang S. Enhanced dissolution rate and oral bioavailability of simvastatin nanocrystal prepared by sonoprecipitation. Drug Dev Ind Pharm 2012;38:1230-9.
5. Cuong NV, Hsieh MF, Chen YT, Liau I. Synthesis and characterization of peg–PCL–peg triblock copolymers as carriers of doxorubicin for the treatment of breast cancer. J Appl Polym Sci 2010;117:3694-703.
6. Azouz L, Dahmoune F, Rezgui F, G’Sell C. Full factorial design optimization of anti-inflammatory drug release by PCL–PEG–PCL microspheres. Mater Sci Eng C 2016;58:412-9.
7. Hu C, Chen Z, Wu S, Han Y, Wang H, Sun H, et al. Micelle or polymersome formation by PCL-PEG-PCL copolymers as drug delivery systems. Chin Chem Lett 2017;28:1905-9.
8. Alami-milani M, Zakeri-milani P, Valizadeh H, Salehi R, Jelvehgari M. Preparation and evaluation of PCL-PEG-PCL micelles as potential nanocarriers for ocular delivery of dexamethasone. Iran J Basic Med Sci 2018;2:153-64.
9. Barghi L, Asgari D, Barar J. Nakhlband A, Valizadeh H. Synthesis, characterization and in vitro anti-tumoral evaluation of erlotinib-PCEC nanoparticles. Asian Pac J Cancer Prev 2015a;15:10281-7.
10. Danafar H, Rostamizadeh K, Hamidi M. Polylactide/poly(ethylene glycol)/polylactide triblock copolymer micelles as a carrier for delivery of hydrophilic and hydrophobic drugs: a comparison study. J Pharm Investig 2018;48:381-91.
11. Danafar H. Preparation and characterization of PCL-PEG-PCL polymersomes for delivery of clavulanic acid. Cogent Med 2016;3:1-11.
12. Yao J, Ruan Y, Zhai T, Guan J, Tang G, Li H, et al. ABC block copolymer as “smart” pH-responsive carrier for intracellular delivery of hydrophobic drugs. Polymer 2011;5:3396-404.
13. Barghi L, Asgari D, Barar J, Valizadeh H. Synthesis of PCEC copolymers with controlled molecular weight using full factorial methodology. Adv Pharm Bull 2015b;5:51-6.
14. Feng R, Song Z, Zhai G. Preparation and in vivo pharmacokinetics of curcumin-loaded PCL-PEG-PCL triblock copolymeric nanoparticles. Int J Nanomed 2012;7:4089-98.
15. Khanam N, Alam MI, Ali QMAIMY, Siddiqui A. A review on optimization of drug delivery system with experimental designs. Int J Appl Pharm 2018;10:7-12.
16. Bolton S, Bon C. Pharmaceutical statistics: practical and clinical applications, 4th ed rev and expanded. New York: M. Dekker; 2004.
17. Kumar RS, Yagnesh TNS, Kumar VG. Optimization of ibuprofen fast dissolving tablets employing starch xanthate using 23 factorial design. Int J Appl Pharm 2017;9:51-9.
18. Danaei M, Dehghankhold M, Ataei S, Hasanzadeh Davarani F, Javanmard R, Dokhani A, et al. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics 2018;10:1-17.
19. Candioti LV, De Zan MM, Camara MS, Goicoechea HC. Experimental design and multiple response optimization using the desirability function in analytical methods development. Talanta 2014;124:123–38.
20. Pandey SK, Haldar C, Patel DK, Maiti P. Biodegradable polymers for potential delivery systems for therapeutics. In: Dutta PK, Dutta J. editors. Multifaceted development and application of biopolymers for biology, biomedicine, and nanotechnology. Berlin: Springer Berlin Heidelberg; 2013. p. 169-202.
21. Musmade KP, Deshpande PB, Musmade PB, Maliyakkal MN, Kumar AR, Reddy MS, et al. Methotrexate-loaded biodegradable nanoparticles: preparation, characterization, and evaluation of its cytotoxic potential against U-343 MGa human neuronal glioblastoma cells. Bull Mater Sci 2014;37:945–51.
This work is licensed under a Creative Commons Attribution 4.0 International License.